The AI transformation in pharma Artificial intelligence (AI) is revolutionising the pharmaceutical industry in unprecedented ways. From accelerating drug discovery to enhancing molecular design and predicting drug safety profiles, AI technology is significantly reducing the time required to bring new medicines from the laboratory to market. At the ‘Pharma meets AI’ Ubiq event in Barcelona this April, Antonio Velasco, Chief Information Officer (CIO) at AstraZeneca, shared groundbreaking insights.